NCT05925608 - Clinical Trial of Human Allogenic Culture-expanded Bone Marrow-derived Mesenchymal Stem Cells | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 23, 2023

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2025

Conditions

Heart Failure, Systolic

Interventions

COMBINATION_PRODUCT

CardiALLO™ Human Allogenic Culture-expanded Bone marrow-derived Mesenchymal Stem Cells (hMSCs)

CardiALLO™ Human Allogenic Culture-expanded Bone marrow-derived Mesenchymal Stem Cells (hMSCs) delivered with the Helix transendocardial delivery catheter (treatment)

DIAGNOSTIC_TEST

Diagnostic Catheterization

Left ventricular catheterization with no active therapy

Trial Locations (1)

36210

University of Florida, Gainesville